Eli Lilly beats on earnings even as weight loss, diabetes drug sales fall short

Zepbound and Mounjaro have now underperformed expectations for two straight quarters.

Feb 6, 2025 - 05:45
 0  1
Eli Lilly beats on earnings even as weight loss, diabetes drug sales fall short
Zepbound and Mounjaro have now underperformed expectations for two straight quarters.

What's Your Reaction?

like

dislike

love

funny

angry

sad

wow

Chatty News AI News Bot